Hevert Lymphaden comp. (Hevert Pharmaceuticals LLC)


Welcome to the PulseAid listing for the Hevert Lymphaden comp. drug offered from Hevert Pharmaceuticals LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hevert Pharmaceuticals LLC
NON-PROPRIETARY NAME: Arsenic Trioxide, Clematis Recta Flowering Top, Lachesis Muta Venom, Mercuric Cyanide, Phytolacca Americana Root, Toxicodendron Pubescens Shoot, Scrophularia Nodosa Leaf With Stem, Sulfur, and Thuja O
SUBSTANCE NAME: ARSENIC TRIOXIDE; CLEMATIS RECTA FLOWERING TOP; LACHESIS MUTA VENOM; MERCURIC CYANIDE; PHYTOLACCA AMERICANA ROOT; TOXICODENDRON PUBESCENS SHOOT; SCROPHULARIA NODOSA LEAF WITH STEM; SULFUR; THUJA OCCID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-06-01
END MARKETING DATE: 0000-00-00


Hevert Lymphaden comp. HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHevert Lymphaden comp. from Hevert Pharmaceuticals LLC
LABELER NAME: Hevert Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 4; 8; 8; 6; 6; 4; 6; 4([hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL)
START MARKETING DATE: 2016-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54532-0029_cec5e7a0-46ac-46dc-864d-00e302b034f3
PRODUCT NDC: 54532-0029
APPLICATION NUMBER:

Other ARSENIC TRIOXIDE; CLEMATIS RECTA FLOWERING TOP; LACHESIS MUTA VENOM; MERCURIC CYANIDE; PHYTOLACCA AMERICANA ROOT; TOXICODENDRON PUBESCENS SHOOT; SCROPHULARIA NODOSA LEAF WITH STEM; SULFUR; THUJA OCCID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hevert Pharmaceuticals LLCHevert Lymphaden comp.